China International Medicinal Equipment Fair (CMEF)
view counter

Category: RenalSyndicate content

Renal

NxStage inks Scandinavian distribution deal with Nordic Medcomm

February 3, 2010 by MassDevice staff

NxStage Medical Inc. signed a five-year distribution deal with Nordic Medcomm AB to distribute its System One home hemodialysis system in Sweden, Denmark and Finland.

NXTM logo

NxStage Medical Inc. (NSDQ:NXTM) inked a five-year deal with Nordic Medcom AB that will see the Swedish firm distribute NxStage's System One home hemodialysis system in Scandinavia.

Lawrence, Mass.-based NxStage said the terms of the deal includes the exclusive right for Nordic Medcomm to sell the home dialysis system and its PureFlow SL dialysate preparation system to dialysis centers in Sweden, Denmark and Finland. Nordic Medcomm can also choose to sell NxStage's Medisystems bloodlines and ButtonHole needles.

Spire closes hemodialysis catheter business sale to C.R. Bard

January 25, 2010 by MassDevice staff

Spire Corp. is now mostly a clean energy company, after it closed the sale of its hemodialysis catheter business to C.R. Bard late last year for less than originally agreed.

SPIR logo

Spire Corp. (NSDQ:SPIR) closed the sale of its hemodialysis catheter business to a division of C.R. Bard (NYSE:BCR) Dec. 16, after postponing the merger several times and agreeing to accept $2.5 million less than the original offer.

In September 2009, Spire agreed to sell the seven-year-old operation to the Salt Lake City-based device maker's Bard Access Systems division for $15 million, so it could focus on its core solar energy business.

NxStage taps new international VP, GM

January 19, 2010 by MassDevice staff

NxStage Medical Inc. named John Mullen to lead its growth initiatives overseas.

NXTM logo

NxStage Medical Inc. (NSDQ:NXTM) tapped John Mullen to fill its newly created international general manager position.

The Lawrence, Mass.-based home dialysis products maker said Mullen will be its vice president and general manager, international, charged with leading NxStage's growth initiatives overseas.

Spire, Bard postpone merger. Again.

December 7, 2009 by MassDevice staff

Spire Corp. and C.R. Bard agreed to postpone the $15 million buyout of Spire's hemodialysis catheter business for the third time, setting a new deadline for Dec. 11.

Spire, Bard postpone merger. Again.

C.R. Bard (NYSE:BCR) has until the end of the week to consummate its $15 million deal for Spire Corp.'s (NSDQ:SPIR) hemodialysis catheter business — unless the companies decide to postpone the buyout for the fourth time.

PLC Systems widens losses, inks Brazilian distribution deal

November 10, 2009 by MassDevice staff

The cardiovascular devices maker posts a 36 percent sales plunge as net losses widen and it inks a distribution deal with Brazil's Discomed for its RenalGuard device.

PLC Systems widens losses, inks Brazilian distribution deal

Three months ago PLC Systems Inc. hit a double, halving its second-quarter net losses and signing a distribution deal for Bangladesh and Pakistan.

Positive study results buoy NxStage

October 27, 2009 by MassDevice staff

A study showing patients using its home dialysis technology need less anti-hypertensive medications sends the Lawrence, Mass.-based hemodialysis firm's stock up nearly 5 percent.

Positive study results buoy NxStage

Positive interim results from a study of NxStage Medical Inc.'s home dialysis technology sent the Lawrence, Mass.-based firm's stock soaring.

The hemodialysis device maker said interim results from its Freedom study show that patients performing daily home hemodialysis treatments needed significantly less anti-hypertensive medication than when they were treated at hemodialysis centers.

As of about 12:40 p.m. Oct. 27, NxStage stock was up 4.7 percent, trading at $5.97 per share.

Boston Scientific buys the distribution rights to Pluromed's BackStop

October 9, 2009 by MassDevice staff

The Natick, Mass.-based medical devices giant will distribute the Woburn firm's kidney stone treatment worldwide.

Boston Scientific buys the distribution rights to Pluromed's BackStop

Boston Scientific Corp. spent an undisclosed amount for the worldwide distribution rights to Pluromed Inc.'s BackStop polymer gel plug for treating kidney stones.

browse jobs and career opportunities in the medical devices industry
view counter
PACIFIC BRIDGE MEDICAL (PBM) is a leading Asia medical consulting firm dedicated to assisting medical companies in Asia.
view counter
Free Literature and Charts from Emergo Group
view counter
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp